Overview of Dr. Hashmi
Dr. Hamza Hashmi is a hematologist in New York, NY and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center and MUSC Health University Medical Center. He received his medical degree from King Edward Medical University and has been in practice 12 years. He is one of 11 doctors at MUSC Health University Medical Center and one of 62 doctors at Memorial Sloan Kettering Cancer Center who specialize in Hematology. He has more than 60 publications and over 300 citings.
Office
530 East 74th Street
New York, NY 10021
Education & Training
Corewell Health – Grand Rapids/Michigan State UniversityResidency, Internal Medicine, 2013 - 2016
King Edward Medical UniversityClass of 2011
Certifications & Licensure
NJ State Medical License 2023 - 2025
NY State Medical License 2023 - 2025
SC State Medical License 2020 - 2025
KY State Medical License 2016 - 2020
MI State Medical License 2013 - 2016
VA State Medical License 2014 - 2015- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Bispecific antibodies targeting BCMA or GPRC5D are highly effective in relapsed myeloma after CAR T-cell therapy.Maximilian Merz, Danai Dima, Hamza Hashmi, Nausheen Ahmed, Friedrich Stölzel
Blood Cancer Journal. 2024-12-05 - Safety and efficacy of B cell maturation antigen-directed CAR T-cell therapy in patients with relapsed/refractory multiple myeloma and concurrent light chain amyloidosis.Utkarsh Goel, Danai Dima, James Davis, Nausheen Ahmed, Hira Shaikh
European Journal of Haematology. 2024-12-01 - Addition of Elotuzumab to Backbone Treatment Regimens for Multiple Myeloma: An Updated Meta-Analysis of Randomized Clinical Trials.Bruno Almeida Costa, Thomaz Alexandre Costa, Gabriel Cavalcante Lima Chagas, Tarek H Mouhieddine, Joshua Richter
Clinical Lymphoma, Myeloma & Leukemia. 2024-09-21
Press Mentions
Outpatient Stem Cell Transplants Result in Less Hospitalization Time for Multiple Myeloma Patients, Study FindsJuly 6th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
